Updated News

Initial laboratory studies on the Omicron SARS-CoV-2 variant showed that it is highly likely to compromise the protection provided by COVID vaccines. The researchers, which include teams from South Africa, Germany, and Sweden, as well as the Pfizer-BioNtech collaboration, said that the COVID vaccine protection would still be useful, especially with boosters.